YUHSpace: Dept. of Internal Medicine (내과학교실)

YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

Dept. of Internal Medicine (내과학교실)

Researcher List

Keyword Cloud

Journal Categories

Hot Articles

Trastuzumab in combination with chemotherapy versus chemotherapy alone f...

Yung-Jue Bang ; Eric Van Cutsem ; Andrea Feyereislova ; Hyun C Chung ; Lin Sh... LANCET, Vol.376(9742) : 687-697, 2010

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Jean-Charles Soria ; Yuichiro Ohe ; Johan Vansteenkiste ; Thanyanan Reungwetw... NEW ENGLAND JOURNAL OF MEDICINE, Vol.378(2) : 113-125, 2018

Cetuximab and chemotherapy as initial treatment for metastatic colorecta...

Eric Van Cutsem ; Claus-Henning Köhne ; Erika Hitre ; Jerzy Zaluski ; Chung-R... NEW ENGLAND JOURNAL OF MEDICINE, Vol.360(14) : 1408-1417, 2009

PDF Read more

This table browses all dspace content
Issue Date	Title	Journal Title
2019	Association Between Serum High-Density Lipoprotein Cholesterol Levels and Progression of Chronic Kidney Disease: Results From the KNOW-CKD	JOURNAL OF THE AMERICAN HEART ASSOCIATION
2019	Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference	KIDNEY INTERNATIONAL
2019	Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference	KIDNEY INTERNATIONAL
2019	The Ratio of Peripheral Regulatory T Cells to Lox-1+ Polymorphonuclear Myeloid-derived Suppressor Cells Predicts the Early Response to Anti-PD-1 Therapy in Patients with Non-Small Cell Lung Cancer	AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
2019	Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial	LANCET
2019	Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial	LANCET
2019	Eosinophilic Granulomatosis with Polyangiitis: Experiences in Korean Patients	Yonsei Medical Journal
2019	In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia	SCIENTIFIC REPORTS
2019	A cost per responder analysis of secukinumab vs adalimumab for the treatment of ankylosing spondylitis from the Korean perspective	INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
2019	Efficacy and Safety of Besifovir Dipivoxil Maleate Compared With Tenofovir Disoproxil Fumarate in Treatment of Chronic Hepatitis B Virus Infection	CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2019	Failure of hepatocellular carcinoma surveillance: inadequate echogenic window and macronodular parenchyma as potential culprits	ULTRASONOGRAPHY
2019	Atializumab, a humanized anti-aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) antibody significantly improves nephritis in (NZB/NZW) F1 mice	BIOMATERIALS
2019	Second Asian Consensus on Irritable Bowel Syndrome	JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY
2019	MALDI-TOF Mass Spectrometry Based on Parylene-Matrix Chip for the Analysis of Lysophosphatidylcholine in Sepsis Patient Sera	ANALYTICAL CHEMISTRY
2019	Late complications after hybrid aortic arch repair	JOURNAL OF VASCULAR SURGERY
2019	Nonalcoholic fatty liver disease is an early predictor of metabolic diseases in a metabolically healthy population	PLOS ONE
2019	Staged partial hepatectomy versus transarterial chemoembolization for the treatment of spontaneous hepatocellular carcinoma rupture: a multicenter analysis in Korea	ANNALS OF SURGICAL TREATMENT AND RESEARCH
2019	Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis	SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
2019	Therapeutic Outcome of Achalasia Based on High-Resolution Manometry: A Korean Multicenter Study	AMERICAN JOURNAL OF THERAPEUTICS
2019	Dual-targeting of EGFR and Neuropilin-1 attenuates resistance to EGFR-targeted antibody therapy in KRAS-mutant non-small cell lung cancer	CANCER LETTERS